Dale Broadrick - Jul 6, 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
10%+ Owner
Signature
/s/ Dale Broadrick
Stock symbol
BRTX
Transactions as of
Jul 6, 2022
Transactions value $
$3,611
Form type
4
Date filed
7/15/2022, 11:46 AM
Previous filing
Jul 5, 2022
Next filing
Sep 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $338 +100 +0.03% $3.38 297K Jul 6, 2022 Direct
transaction BRTX Common Stock Purchase $2.67K +900 +0.3% $2.97 298K Jul 12, 2022 Direct F1
transaction BRTX Common Stock Purchase $600 +200 +0.07% $3.00 299K Jul 13, 2022 Direct
holding BRTX Common Stock 317K Jul 6, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Warrant to acquire Common Stock 125 Jul 6, 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 125 Jul 6, 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 Jul 6, 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 Jul 6, 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 833 Jul 6, 2022 Common Stock 833 $120.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $2.95 to $2.9799 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F2 Owned by Fleetco, Inc. of which reporting person is a 93% shareholder.